Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 43Liver Neoplasms 14Colorectal Neoplasms 11Recurrence 6Cholangiocarcinoma 6Neoplasm Metastasis 5Pancreatic Neoplasms 3Colonic Neoplasms 3Rupture, Spontaneous 2Stomach Neoplasms 1Sarcopenia 1Reperfusion Injury 1Postoperative Complications 1Obesity, Morbid 1Metabolic Syndrome 1Liver Failure 1Klatskin Tumor 1Ischemia 1Hypertension, Portal 1Focal Nodular Hyperplasia 1Fibrosis 1Disseminated Pancreatic Cancer 1Disease Progression 1Conversion Disorder 1Colorectal Cancer Metastatic 1Cirrhosis, Familial, with Pulmonary Hypertension 1Carcinoma 1Abdominal Injuries 1

Interventions

Gemcitabine 685130-nm albumin-bound paclitaxel 199Fluorouracil 190Oxaliplatin 177Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 133Irinotecan 114Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 73Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 51Cyclophosphamide 49folfirinox 45Specimen Handling 43Docetaxel 42Cetuximab 40Biopsy 39irinotecan sucrosofate 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Hepatectomy × Gastrointestinal × Clear all
NCT02892305 2025-08-06

Hepatic Resection for Metastatic Pancreatic Cancer

Duke University

Active not recruiting
18 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT06980792 2025-05-20

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Azienda Ospedaliero-Universitaria di Modena

Completed
90 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT03801915 2023-03-21

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡